Accession Number: | 0001209191-22-028686 |
Date: | 2022-05-11 |
Issuer: | TRAVERE THERAPEUTICS, INC. (TVTX) |
Original Submission Date: |
BRUHN SUZANNE LOUISE
C/O TRAVERE THERAPEUTICS, INC.
3611 VALLEY CENTRE DR., SUITE 300
SAN DIEGO, CA 92130
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-05-11 | A | 3,000 | a | $0.00 | 11,250 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 21.38 | 2022-05-11 | deemed execution date | A | 9,000 (a) | 2023-05-11 | 2032-05-10 | common stock 9,000 | $21.38 | 9,000 | direct |
ID | footnote |
---|---|
f1 | automatic equity grant under the issuer's 2018 equity incentive plan, as amended, pursuant to the non-employee director compensation program. |
f2 | the equity award vests over a one year period. |